[
  {
    "ts": null,
    "headline": "Jim Cramer on Becton, Dickinson: “I Kind of Really Like the New Company”",
    "summary": "Becton, Dickinson and Company (NYSE:BDX) is one of the stocks in focus on Jim Cramer’s game plan. Cramer showed bullish sentiment toward the company, as he said: Now, there’s been some incredible moves happening in the medical devices distribution space this quarter. The once unsinkable Boston Scientific got clobbered this week because the competition got […]",
    "url": "https://finnhub.io/api/news?id=ff67fcd3dda7f6ebad406309b8486173b0e656688f97b2337ba5c01d747d8334",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770739118,
      "headline": "Jim Cramer on Becton, Dickinson: “I Kind of Really Like the New Company”",
      "id": 139032013,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Becton, Dickinson and Company (NYSE:BDX) is one of the stocks in focus on Jim Cramer’s game plan. Cramer showed bullish sentiment toward the company, as he said: Now, there’s been some incredible moves happening in the medical devices distribution space this quarter. The once unsinkable Boston Scientific got clobbered this week because the competition got […]",
      "url": "https://finnhub.io/api/news?id=ff67fcd3dda7f6ebad406309b8486173b0e656688f97b2337ba5c01d747d8334"
    }
  },
  {
    "ts": null,
    "headline": "4 takeaways from the 2026 AF Symposium",
    "summary": "Johnson & Johnson, Boston Scientific and Abbott were among the companies showcasing new data on atrial fibrillation treatments, including pulsed field ablation catheters.",
    "url": "https://finnhub.io/api/news?id=e3bcd33d57506be4bd093293ac58acff6274ad467a547dd8b0d2811c3636b17a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770720830,
      "headline": "4 takeaways from the 2026 AF Symposium",
      "id": 139033426,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Johnson & Johnson, Boston Scientific and Abbott were among the companies showcasing new data on atrial fibrillation treatments, including pulsed field ablation catheters.",
      "url": "https://finnhub.io/api/news?id=e3bcd33d57506be4bd093293ac58acff6274ad467a547dd8b0d2811c3636b17a"
    }
  },
  {
    "ts": null,
    "headline": "Becton, Dickinson and Company: A Q1 2026 Earnings And Post Spin-Off Examination",
    "summary": "Becton, Dickinson and Company: A Q1 2026 Earnings And Post Spin-Off Examination",
    "url": "https://finnhub.io/api/news?id=d1f7b3aff4efceb35e057ee920fde62c364f280d994739d721d4e395f4401aac",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770711346,
      "headline": "Becton, Dickinson and Company: A Q1 2026 Earnings And Post Spin-Off Examination",
      "id": 139028876,
      "image": "",
      "related": "BSX",
      "source": "SeekingAlpha",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=d1f7b3aff4efceb35e057ee920fde62c364f280d994739d721d4e395f4401aac"
    }
  },
  {
    "ts": null,
    "headline": "Soft Start For $10B-Plus M&A Deals In 2026",
    "summary": "Soft Start For $10B-Plus M&A Deals In 2026",
    "url": "https://finnhub.io/api/news?id=5b975666cd2cc991adb29292fe8708d0da43773639619847b35723472d3cc002",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770706140,
      "headline": "Soft Start For $10B-Plus M&A Deals In 2026",
      "id": 139028286,
      "image": "",
      "related": "BSX",
      "source": "SeekingAlpha",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=5b975666cd2cc991adb29292fe8708d0da43773639619847b35723472d3cc002"
    }
  }
]